Senseonics Holdings Inc. (SENS)
SENS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1616543/000110465926022298/0001104659-26-022298-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SENS on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001616543 |
| SEC industry code | Industrial Instruments For Measurement, Display, and Control |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $35.3M |
| Net income | -$69.1M |
| Operating income | -$68.3M |
| Net margin | -196.0% |
| Operating margin | -193.8% |
| Revenue growth | +56.9% |
| Cash | $40.2M |
| Total assets | $126.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 16.9× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-09 |
| Cash and burn | $47.8M cash; operating cash flow -$28.3M a quarter. | Report 2026-09-30 |
| Shares outstanding | 54,780,508 (2026-11-03); 40,858,460 a year earlier; 528,281,405 three years earlier. 3y figure adjusted for split (1-for-20 overall). | Cover page 2026-11-03 |
| Reverse splits, 3 years | 1; latest 1-for-20 on 2025-10-20 | Source 2025-10-20 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-05-01 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25 filed | 25 2025-11-14 |
| Auditor | KPMG LLP, Baltimore, Maryland, United States | PCAOB Form AP 2026-03-30 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $737K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $19.6M | -$32.7M | -$32.9M | $47.8M | $54.2M | $60.0M | 10-Q 2026-11-09 |
| Q2 2026 2026-06-30 | $14.5M | -$36.7M | -$30.1M | $44.8M | $55.8M | $48.5M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $11.7M | -$32.3M | -$32.0M | $29.6M | $35.9M | $40.7M | 10-Q 2026-05-07 |
| Q4 2025 2025-12-31 | $14.3M | -$20.8M | -$18.0M | $40.2M | $35.6M | $35.3M | 10-K 2026-03-02 |
| Q3 2025 2025-09-30 | $8.1M | -$19.5M | -$15.8M | $34.5M | $35.3M | $29.3M | 10-Q 2026-11-09 |
| Q2 2025 2025-06-30 | $6.6M | -$14.5M | -$9.3M | $31.5M | $35.2M | $25.5M | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $6.3M | -$14.3M | -$16.1M | $39.3M | $35.0M | $23.7M | 10-Q 2026-05-07 |
| Q4 2024 2024-12-31 | $8.3M | -$15.5M | -$14.2M | $74.6M | $34.7M | $22.5M | 10-K 2026-03-02 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-01 |
| Latest annual report | 10-K | 2026-03-02 |
| Latest quarterly / interim | 10-Q | 2026-11-09 |
| Latest current report | 8-K | 2026-11-09 |
| Latest proxy | DEFA14A | 2026-04-06 |
Source: SEC EDGAR submissions feed, 902 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +23.2% |
| 1 month | +18.6% |
| 3 months | +36.9% |
| Year to date | +91.7% |
| 1 year | +71.2% |
| From 52-week high | 0.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TCMD | Tactile Systems Technology Inc. | $26.37 | -1.64% | $590.7M |
| SGHT | Sight Sciences Inc. | $10.59 | -2.22% | $588.6M |
| DCTH | Delcath Systems Inc. | $19.87 | -3.31% | $691.2M |
| ANGO | AngioDynamics Inc. | $11.78 | -0.76% | $495.4M |
| RCEL | Avita Medical Inc. | $15.22 | -2.62% | $478.2M |
| CARL | Carlsmed Inc. | $17.35 | +1.34% | $475.5M |
| MDXG | MiMedx Group Inc | $3.18 | -0.93% | $464.0M |
| MOBI | Mobia Medical Inc. | $13.15 | -0.15% | $438.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier